Biotech Archives - Page 682 of 795

1 minute read

ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate

September 28, 10:24 AM

ASLAN Pharmaceuticals (NASDAQ:ASLN) announced the presentation of new translational eblasakimab data at the Annual European Society for Dermatological Research (ESDR) Meeting. …

ASLN

1 minute read

Europe’s Health Agency Accepts Moderna’s Filing For Its Updated Omicron-Targeted COVID-19 Vaccine

By Vandana Singh

September 28, 10:16 AM

The European Medicines Agency (EMA) has accepted a variation for evaluating Moderna Inc’s (NASDAQ:MRNA) 50 µg booster dose of the Omicron-containing…

MRNA

1 minute read

FDA
News

Zhongchao Establishes Chongqing Xinjiang Pharmaceutical To Improve Patient Access To Medications

By Benzinga Newsdesk

September 28, 9:25 AM

Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced

ZCMD

6 minute read

Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen’s New Drug Slows Alzheimer’s Progression: Top Financial Media Stories Wednesday, Sept. 28

By Vandana Singh

September 28, 9:02 AM

Bloomberg

AAPL

2 minute read

Sight Sciences To Feature Interactive Panel Discussions Of Real-World Use Of The OMNI Surgical System As A Standalone Glaucoma Treatment At American Academy Of Ophthalmology Annual Meeting October 1-2

By Benzinga Newsdesk

September 28, 8:39 AM

MENLO PARK, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), today announced that 12 ophthalmic physicians will present their first-hand experience using the OMNI Surgical System as a

SGHT

2 minute read

RenovoRx Announces Presentation At Symposium On Clinical Interventional Oncology Highlighting Its Innovative Therapy Platform For Targeted Treatment Of Pancreatic Cancer

By Benzinga Newsdesk

September 28, 8:37 AM

RenovoRx, Inc. (NASDAQ:RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMPTM) therapy

RNXT

3 minute read

HeartBeam Granted Patent For Signal Transformation From Vector Electrocardiogram To 12-Lead Electrocardiogram

By Benzinga Newsdesk

September 28, 8:33 AM

Patented Technology Allows HeartBeam AIMIGo™ Credit Card-sized Device to Enable a 12-lead ECG Anytime, Anywhere HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first

BEAT

1 minute read

CinCor Pharma Announces Late-Breaking Presentation Of Phase 2 BrigHtn Data For Baxdrostat In Treatment-Resistant Hypertension At The Upcoming 2022 American Heart Association Scientific Sessions : November 7

By Benzinga Newsdesk

September 28, 8:27 AM

WALTHAM, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ:CINC) today announced that the company will present Phase 2 data from its BrigHtn trial evaluating baxdrostat in patients with

CINC

1 minute read

Thermo Fisher’s Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers

By Vandana Singh

September 28, 8:11 AM

The FDA approved Thermo Fisher Scientific Inc’s (NYSE:TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to select patients with RET-fusion…

LLY

1 minute read

Rallybio Announces Preliminary Results For RLYB212, An Anti-HPA-1a Monoclonal Antibody For The Prevention Of Fetal And Neonatal Alloimmune Thrombocytopenia

By Benzinga Newsdesk

September 28, 8:08 AM

Rallybio Corporation (NASDAQ:RLYB) today announced positive preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212, an anti-HPA-1a monoclonal antibody for the prevention of fetal and neonatal

RLYB